Due to the nature of the private label agreement, the name of the medical supply company cannot be made public.
‘We are delighted to formally announce this new contract, which is a milestone for Derma Sciences and illustrates the promise inherent in our recently acquired First Aid Division (FAD),’ said chief executive officer Ed Quilty. ‘We knew the FAD was a business unit with great potential, once the cost of manufacturing issues were sorted out. The contract illustrates the excellent operational condition of our FAD and is a prime example of why we purchased the division. We believe investors will now begin to see not only the improved costs associated benefits to our bottom line, but also will see accelerated top-line revenue growth as well.’
